U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07312773) titled 'A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C' on Dec. 17, 2025.
Brief Summary: To evaluate the pharmacokinetic interactions of AD-231A, AD-231B, and AD-231C in healthy adult volunteers.
Study Start Date: Jan. 23
Study Type: INTERVENTIONAL
Condition:
Hypertension
Hyperlipidemia
Intervention:
DRUG: Treatment A(AD-231A)
AD-231A Oral Tablet
DRUG: Treatment B(AD-231B+AD-231C)
AD-231B+AD-231C Oral Tablet
DRUG: Treatment C(AD-231A+AD-231B+AD-231C)
AD-231A+AD-231B+AD-231C Oral Tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Addpharma Inc.
Disclaimer: Curated by HT ...